Loading...
Loading...
In a company update published earlier today, Citigroup Inc. reiterated its Sell rating for Walgreen Co.
WAG, but lowered its price target from $29.00 to $27.00.
Citigroup went on to say “WAG announced a 45% equity stake in Alliance Boots, a global drug retailer with over 3,330 stores in 11 countries. The transaction is expected to be accretive to EPS by $0.23 to $0.27 in its first year. WAG will invest approx. $6.7B in cash and stock in exchange for the stake, with the option to acquire the remaining 55% in approx. three years. Expected pro-forma revenue is approx. $130B by 2016. While the transaction creates some global opportunities, we believe it does not resolve WAG's issues in the U.S.”
Walgreen Co. closed yesterday at $30.09.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in